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heart failure (n = 201) were investigated separately, no 
associations between egg consumption and stroke and MI 
were identified, however, increased risk of stroke in subjects 
with T2D and/or impaired glucose tolerance (IGT, fasting 
plasma glucose ≥ 6.1 mmol/L), adjusted hazard ratios (95% 
CI) were 1.0 (reference), 1.09 (0.41, 2.88), 0.96 (0.37, 2.50), 
1.39 (0.54, 3.56) and 2.87 (1.13, 7.27) for egg intake (n) of 
0 ≤ n ≤ 1, 1 < n ≤ 2, 2 < n ≤ 3, 3 < n < 5, and n ≥ 5 eggs/wk, 
respectively (P = 0.01). In addition, cross-sectional analy-
ses revealed that higher egg consumption was significantly 
associated with elevated fasting glucose in those with T2D 
and/or IGT (CAPS: baseline P = 0.02 and 5-year P = 0.04; 
NDNS: P = 0.05).
Conclusions Higher egg consumption was associated with 
higher blood glucose in subjects with T2D and/or IGT. The 
increased incidence of stroke with higher egg consump-
tion among T2D and/or IGT sub-group warrants further 
investigation.
Keywords Eggs · Cardiovascular disease · Type 2 
diabetes · Impaired glucose tolerance · All-cause mortality
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Abstract 
Purpose The association between egg consumption and 
cardiovascular disease (CVD) or type 2 diabetes (T2D) 
remains controversial. We investigated the association 
between egg consumption and risk of CVD (primary out-
come), T2D and mortality in the Caerphilly prospective 
cohort study (CAPS) and National Diet and Nutritional 
Survey (NDNS).
Methods CAPS included 2512 men aged 45–59 years 
(1979–1983). Dietary intake, disease incidence and mortal-
ity were updated at 5-year intervals. NDNS included 754 
adults aged 19–64 years from 2008 to 2012.
Results Men free of CVD (n = 1781) were followed up for 
a mean of 22.8 years, egg consumption was not associated 
with new incidence of CVD (n = 715), mortality (n = 1028) 
or T2D (n = 120). When stroke (n = 248), MI (n = 477), 
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HbA1c  Glycated haemoglobin
ICD  International Classification of Diseases
HR  Hazard ratio
Introduction
Cardiovascular diseases (CVD) are still the leading cause 
of morbidity and mortality, and the prevalence of type 2 
diabetes mellitus (T2D) is also increasing globally. Diet 
plays an important role in prevention and management of 
both CVD [1] and T2D [2]. Eggs are a good source of a 
number of nutrients in the UK diet such as vitamin D, sele-
nium, vitamin K and choline as well as high quality protein 
[3]. However, eggs also contain relatively high amounts of 
dietary cholesterol (350 mg/100 g) [4], which has been asso-
ciated with impaired glucose metabolism [5] and increased 
inflammation [6] in animal models and with elevated fasting 
glucose in humans [7]. Furthermore, meta-analyses of inter-
vention studies have shown that high consumption of dietary 
cholesterol increases serum total, LDL- and HDL-choles-
terol concentrations, as well as the ratio of total to HDL-
cholesterol [8, 9], all key risk factors of CVD, although it 
has been proposed that these changes are small and are not 
clinically significant [10].
Evidence for the association between egg consumption 
and glycaemic control is limited. Findings from a rand-
omized controlled trial (RCT) of 140 overweight or obese 
subjects with prediabetes or T2D showed that high-egg con-
sumption (2 eggs/day for 6 days/week) did not adversely 
effect lipid profiles of those with T2D [11]. Furthermore, 
Fuller et al. [11] reported no effect of egg intake on gly-
caemic control in a 3-month RCT in subjects with T2D, 
whereas an inverse association between egg intake and fast-
ing plasma glucose was reported in a prospective cohort 
study [12]. Moreover, evidence from previous meta-anal-
yses in relation to egg consumption and CVD risk showed 
inconsistent results. Some studies [13, 14] have shown that 
consumption of up to one egg per day is not associated with 
increased risk of CVD in the general population, which is 
in contrast to a recent meta-analysis which reported up to 
one egg per day was associated with reduced risk of stroke 
[15]. Furthermore, inconsistent associations between egg 
intake and CVD in diabetic patients were observed. Shin 
et al. [14] concluded that consumption of up to one egg per 
day was associated with an increased risk of CVD in those 
suffering from T2D, whereas Rong et al. [13] found intake 
of up to one egg per day was associated with an increased 
risk of CHD in diabetic patients, but may have contributed 
to a reduced risk of hemorrhagic stroke in this sub-group.
Due to the inconsistent reported relationship between 
egg consumption and cardio-metabolic disease incidence 
and risk we investigated the association between egg con-
sumption and incidence of CVD (primary outcome) and all-
cause mortality and incidence of T2D (secondary outcomes) 
in middle-aged men from the UK Caerphilly Prospective 
Cohort Study (CAPS). Furthermore, due to the different 
pathophysiologies of diseases classed as CVD, including 
myocardial infarction (MI), stroke and heart failure [16], 
the relationship between these diseases and egg consump-
tion were further investigated separately. Furthermore, the 
cross-sectional relationships between egg intake and a num-
ber of cardiometabolic risk markers were investigated using 
data from the CAPS and the UK National Diet and Nutri-
tion Survey (NDNS) rolling programme (years 1–4, second-
ary outcomes) cross-sectionally. Our hypothesis was that a 
higher egg intake was unlikely to increase the risk of CVD 
(including MI, stroke, heart failure and cardio-metabolic risk 
markers), T2D or all-cause mortality, but may have detri-
mental effects in those suffering from T2D.
Subjects and methods
Caerphilly prospective cohort study
Study population of caerphilly prospective cohort study
The CAPS was set up between 1979 and 1983 and was 
designed to investigate CVD risk factors in men, there was 
follow-up of the men who were re-examined at 5-year inter-
vals (Fig. 1). Initially, 2512 men aged 45–59-years-old liv-
ing in Caerphilly, Wales, United Kingdom and the adjacent 
area were recruited onto the study [17]. However, 561 men 
decided to leave the study after Phase 1 (1979–1983) and an 
additional group of 447 men were recruited for replacement, 
giving a new total of 2398 men at Phase 2 (1984–1988). 
At 5 years later, a total of 2147 men revisited the clinical 
centre for the Phase 3 examination (1989–1993). The cur-
rent study has not included data from Phase 1, as there were 
an inconsistent population and number of subjects between 
Phase 1 and Phase 2.
Fig. 1  Timeline of the caer-
philly prospective cohort study
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Dietary assessment
Diet was assessed at both Phase 2 and Phase 3 with the use 
of a semi-quantitative food-frequency questionnaire (FFQ). 
Participants were asked to report the number of eggs con-
sumed on a weekly basis, with one unit of consumption 
equivalent to one egg, however, this excluded eggs present 
in composite dishes. This FFQ was previously validated 
using a 7-day weighed diet diary in a representative sub-
group of 665 men, representing 30% of Phase 1 participants 
[18]. To present the best estimation of egg consumption, the 
mean egg intake of Phase 2 and Phase 3 was used for the 
longitudinal analysis, which also allowed estimation of the 
effect of the cumulative long-term diet. Subjects with pre-
existing stroke (n = 60), MI (n = 98), and those with missing 
data (including subjects who dropped out during the follow-
up period) or confounding factors (n = 208) were excluded 
from the longitudinal CVD analysis, which left a total of 
1781 men. Subjects with pre-existing stroke, MI were also 
excluded from cross-sectional analyses at Phase 2 or Phase 
3. Furthermore, subjects with pre-existing T2D (n = 94) were 
excluded from the longitudinal T2D analysis, which left a 
total 1687 men. The mean egg intakes at Phase 2 and Phase 
3 were calculated for all of the subjects who reported egg 
consumption in both phases. Egg consumption (n = number/
week) was divided into five groups for the analysis: 0 ≤ n ≤ 1, 
1 < n ≤ 2, 2 < n ≤ 3, 3 < n < 5, n ≥ 5.
Cardiovascular events, diabetes and all‑cause mortality
The incidence of T2D was self-reported from questionnaires 
in the CAPS. Identification of vascular disease events and 
deaths by cause has been described elsewhere [19–21]. In 
brief, subjects were seen in a central clinic, symptoms and 
illnesses suggestive of a stroke or heart attack were con-
firmed by the use of the London School of Hygiene chest 
pain questionnaire and the Oxford Stroke Questionnaire; 
subjects also had an electrocardiogram measurement dur-
ing the visit. Appropriate searches of hospital and general 
practitioner databases were made to extract relevant clini-
cal information. Vascular events (International Classification 
of Diseases (ICD) 121-5, 10th revision) of fatal ischaemic 
heart disease and non-fatal MI and ischaemic stroke (ICD 
163-4) were diagnosed by two independent expert clinicians 
and an epidemiologist using all available clinical evidence, 
including computed tomography, radiological and pathologi-
cal information. Furthermore, the records of all men in the 
National Health Service Central Registry were flagged so 
that notification of death certificate was received automati-
cally, and cause of death was defined by ICD-9 Revision.
The aim of the present study was to investigate the rela-
tionship between egg intake and CVD or mortality in the 
total population, as well as in a sub-group suffering from 
T2D and/or impaired glucose tolerance (IGT). After removal 
of 16 subjects with T2D who had missing dietary or con-
founding factor data from baseline, 94 pre-existing T2D 
subjects remained for inclusion in the analysis. To have 
sufficient numbers for the statistical analysis, we combined 
the men with IGT (n = 319), defined by the WHO as fast-
ing plasma glucose of 6.1 mmol/L or higher [22]. Subjects 
(n = 73) who met the inclusion criteria for both T2D and 
IGT were counted once in the analysis, thus, T2D and/or 
IGT sub-group included 340 subjects which were included 
in the longitudinal analysis of the associations between egg 
consumption with CVD events or all-cause mortality.
Other measurements
Systolic blood pressure (SBP), diastolic blood pressure 
(DBP), plasma glucose, insulin, triacylglycerol (TAG), total/
HDL-cholesterol, fibrinogen, homocysteine and C-reactive 
protein (CRP) were measured in fasting plasma or serum 
samples at Phase 2. LDL-cholesterol was calculated using 
TAG, total cholesterol and HDL-cholesterol by the Friede-
wald formula [23]. Pulse pressure was calculated by sub-
tracting DBP from SBP. However, only SBP, DPB, glucose, 
TAG, total cholesterol, fibrinogen were measured at Phase 
3 in CAPS.
National diet and nutrition survey
Data files from the National Diet and Nutrition Sur-
vey (NDNS) [24] years 1–4 of the rolling programme 
(2008–2009 to 2011–2012) were obtained from the UK Data 
Archive (http://www.data-archive.ac.uk). The data from 754 
adults (males n = 322 and females n = 432) aged 19–64 years 
were used to determine association between egg intake (g/
day) and fasting blood glucose, glycated haemoglobin 
(HbA1c) and other biochemical measures of cardio-meta-
bolic health, including total-, HDL-, and LDL- cholesterol, 
the total-/HDL- cholesterol ratio, TAG, SBP, DBP, pulse 
pressure and CRP. Food intake was collected using 4-day 
food dairy. Participants with a previous history of stroke 
(n = 1), heart attack or angina (n = 6) were excluded from the 
analysis. In addition, associations between egg consumption 
and metabolic markers were examined in a T2D and/or IGT 
sub-group, which included subjects with T2D (n = 14) or 
IGT (fasting plasma glucose ≥ 6.1 mmol/L, n = 56), subjects 
(n = 11) who met inclusion criteria for both T2D and IGT 
groups were only counted once. Thus, the total number in 
the T2D and/or IGT sub-group was 59 subjects. The egg 
food group included whole eggs and dishes such as ome-
lettes and scrambled eggs, which was analysed as continuous 
variable (with increments of 100 g/day). Composite dishes 
such as egg fried rice and quiches were removed from the 
food group to fit with the analysis conducted on the CAPS.




All data analysis was conducted using STATA (version 13.0; 
STATA Corporation, 2014) and a 2-sided p < 0.05 was con-
sidered statistically significant. In the longitudinal analy-
sis of CAPS, Cox proportional hazard models were used 
to calculate non-adjusted and multivariate adjusted hazard 
ratios (HR) by comparing the time until onset of disease or 
mortality in subjects in the highest intake categories of egg 
consumption with that in the lowest egg group as the refer-
ence group. The survival time for each endpoint (MI, stroke, 
heart failure, T2D or mortality) was the first occurrence of 
an endpoint, death, or the date of receipt of the last follow-
up questionnaire. If subjects had a non-fatal event these data 
were used rather than the later date of death.
The first multivariate model controlled for a number of 
confounding factors in CAPS. These included the covari-
ates age (years), body mass index (weight (kg)/height  (m2)), 
energy intake (kJ/day), alcohol consumption (as ethanol, 
ml/week), smoking (never-smoked, ex-smoked, current 
smoked), energy expenditure (kJ/day), social class (manual 
worker; non-manual worker), family history of MI (yes or 
no) and T2D (yes or no). The second multivariate model also 
controlled for sugar intake (< 50, 50–100, > 100 g/day), fruit 
consumption (< 7, 8–14, 15–21, or > 21 times/week), red 
meat consumption (< 7, 8–14, 15–21, or > 21 times/week) 
and fibre intake (cereal and vegetable sources) (< 10, 10–20, 
or > 20 g/day). The possibility of an interaction between 
egg consumption and subgroup of T2D and/or IGT with 
respect to any of the outcomes was investigated by an analy-
sis including an interaction term in the Cox proportional 
hazard models.
Cross‑sectional analysis in CAPS and NDNS
In secondary analyses, we examined the association between 
egg consumption and metabolic markers in CAPs and 
NDNS. For cross-sectional analysis of CAPs, the associa-
tion of egg consumption with a range of metabolic markers 
was examined at Phase 2. In the sensitivity analyses of cross-
sectional analysis, the associations of egg consumption with 
metabolic markers were also evaluated at Phase 3 to test the 
consistency of the findings. Trends associated with increas-
ing egg consumption were investigated using linear regres-
sion for the continuous variables and logistic regression for 
categorical variables. The same confounding factors used for 
the multivariate models of the longitudinal analysis in CAPS 
were applied in the cross-sectional analysis.
For cross-sectional analysis of the NDNS, the confound-
ing factors used were age (years), gender (men or women), 
energy intake (kJ/day), alcohol consumption (as ethanol, g/
day), T2D (yes or no) and smoking habit (smokers or non-
smokers). General linear regression was used for the analy-
sis. Original data were transformed to natural logarithms if 
required.
Results
CAPS: baseline characteristics according to egg 
consumption
The mean egg intake of 1781 subjects was 2.9 (SD = 2.1) 
eggs per week, and ranged from 0 to 34 eggs per week. 
Among participants, 14.4% subjects consumed 5 eggs or 
more per week. The baseline characteristics of the subjects 
from the CAPS are shown in Table 1. The men in the highest 
quantiles of egg consumption were significantly more likely 
to be manual workers, smokers, consume more alcohol, have 
a higher energy intake and expenditure and a higher BMI. 
They also had a lower incidence of family MI history. After 
controlling for energy intake from foods, the men with the 
highest egg consumption had a significantly higher intake 
of total fat, saturated fat and sugar, but lower cereal or veg-
etable fibre, carbohydrate intakes, red meat and fruit intake.
CAPS: egg consumption and CVD events, all-cause 
mortality and diabetes in longitudinal investigation
During the mean follow-up of 22.8 years, incident cases of 
total CVD event (n = 715) and all-cause mortality (n = 1028) 
were reported in the subjects initially free from CVD events 
(Table 2). When different types of CVD event were investi-
gated separately, egg consumption was not associated with 
incidence of MI (n = 477) or heart failure (n = 201). How-
ever, a significant trend of higher risk of stroke with increas-
ing egg intake (adjusted model P = 0.04) was observed, 
with HR of 1.60 (95% CI: 1.00, 2.57) for the highest (≥ 5 
eggs/week) vs lowest (0 ≤ eggs/week ≤ 1) quantile of egg 
consumption.
In stratified analyses, the prevalence of T2D and/or IGT 
did not influence the association between egg consumption 
and total CVD, MI, heart failure, or all-cause mortality (data 
not shown). When the subjects with T2D and/or IGT were 
removed from the analysis of stroke, there was no signifi-
cant increase in risk of stroke across increasing quantiles of 
egg consumption (Table 3). However, when this analysis 
was performed on the T2D and/or IGT sub-group, a sig-
nificant trend for increased risk of stroke (adjusted model 
P = 0.01) with increasing egg consumption was identified, 
HR for incident stroke was 2.87 (95% CI 1.13, 7.27) in the 
highest vs lowest quantile of egg consumption (P for interac-
tion between egg consumption and T2D and/or IGT = 0.09 
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in non-adjust model, 0.08 in adjusted Model 1 and 0.07 in 
adjusted Model 2).
During the follow-up, a total of 120 new T2D cases were 
diagnosed for subjects initially free from CVD and T2D 
events. There was no association between egg consump-
tion and incident T2D using either un-adjusted or multiple 
adjusted model (Table 4).
CAPS and NDNS: associations between egg 
consumption and cardio-metabolic risk factors: 
cross-sectional analysis
In Phase 2 of the CAPS, no associations were found between 
egg consumption and fasting plasma glucose concentration 
in the subjects free from CVD (Supplemental Table 1). 
However, when the analysis was repeated in a subgroup 
(n = 268) of participants with T2D and/or IGT, there was 
a significant positive association between egg consumption 
and fasting glucose concentration (Supplemental Table 2). 
In this subgroup analysis subjects consuming ≥ 5 eggs/week 
had 1.31 mmol/L higher fasting glucose compared with sub-
jects consuming 1 eggs/wk or less. There were no significant 
associations between egg consumption and other biomarkers 
of CVD risk in the population as a whole (Supplemental 
Table 1) and in subgroup analysis (Supplemental Table 2).
In Phase 3 of the CAPS there was a significant positive 
association between egg consumption and fasting glucose 
concentration (Supplemental Table 3). When the subjects 
with T2D and/or IGT were removed from the analysis, there 
was no association between egg consumption and fasting 
glucose concentration across increasing quantile of egg 
consumption. However, when the analysis was repeated 
in the subgroup of T2D and/or IGT (n = 334) there was a 
significant positive association between egg consumption 
and fasting glucose (Supplemental Table 4). In this sub-
group analysis subjects consuming ≥ 5 eggs per week had 
0.72 mmol/L higher fasting glucose levels compared with 
subjects consuming ≤ 1 eggs/week.
Cross-sectional analysis in NDNS [24] showed egg con-
sumption was positively associated with HbA1c concentra-
tions (Supplemental Table 5). When the subjects with T2D 
and/or IGT were removed from the analysis, there remained 
a significant positive trend for increased egg consumption 
and HbA1c concentration (P = 0.02). In the T2D and/or 
IGT subgroup, egg consumption was significantly associ-
ated with elevated fasting glucose and HbA1c concentrations 
Table 1  Baseline characteristics of participants from the caerphilly prospective cohort study according to egg consumption
All values are mean ± SD
a P-trend was assessed by linear regression (continuous variables) or by logistic regression (categorical variables)
b Energy-adjusted values
Characteristics Egg consumption (n, eggs/wk) P  trenda
(0 ≤ n ≤ 1) (1 < n ≤ 2) (2 < n ≤ 3) (3 < n < 5) (n ≥ 5)
Total subjects, n 274 464 469 318 256
Age, years 61.5 ± 4.6 61.9 ± 4.3 61.7 ± 4.5 61.7 ± 4.5 61.6 ± 4.4 0.93
BMI, kg/m 26.5 ± 3.5 26.5 ± 3.4 26.7 ± 3.7 26.9 ± 4.0 27.1 ± 4.2 0.03
Energy expenditure, kJ/day 1440 ± 1557 1421 ± 1426 1551 ± 1651 1659 ± 1618 1850 ± 2042 0.001
Manual workers, % 53.3 59.7 63.5 70.8 80.1 < 0.001
Family history of MI, % 43.2 38.6 38.4 30.4 36.7 0.02
History of hypertension, % 28.8 26.9 29.2 31.1 29.7 0.40
History of diabetes, % 3.3 1.7 0.9 5.3 3.9 0.07
Current smokers, % 22.6 26.9 36.2 43.4 48.0 < 0.001
Total energy intake, kJ/day 7449 ± 1890 8074 ± 1873 8547 ± 2051 8988 ± 2132 9821 ± 2578 < 0.001
Fat, % of total energy 33.9 35.1 35.8 36.5 37.1 < 0.001
Saturated fat, % of total energy 14.6 15.0 15.5 15.9 16.1 < 0.001
Protein, % of total energy 14.7 14.3 14.3 14.2 14.5 0.19
Carbohydrates, % of total energy 49.3 48.3 47.6 47.1 45.9 < 0.001
Fibre (vegetable sources)b, g/day 11.4 ± 0.5 10.9 ± 0.5 11.1 ± 0.6 11.2 ± 0.6 11.3 ± 0.7 0.02
Fibre (cereal sources)b, g/day 10.8 ± 1.2 10.3 ± 1.1 10.0 ± 1.3 9.3 ± 1.3 9.2 ± 1.6 < 0.001
Sugarb, g/day 76.8 ± 24.1 82.2 ± 23.9 87.3 ± 26.1 93.6 ± 27.2 104.3 ± 32.9 < 0.001
Fruitb, number/week 9.3 ± 0.5 8.3 ± 0.5 7.9 ± 0.6 7.4 ± 0.6 7.7 ± 0.7 < 0.001
Vegetableb, times/week 10.7 ± 4.7 10.0 ± 4.6 10.5 ± 4.7 10.6 ± 4.8 10.3 ± 4.8 0.99
Red  meatb, times/week 17.4 ± 0.9 14.9 ± 0.9 14.8 ± 1.0 14.3 ± 1.1 14.8 ± 1.3 < 0.001
Ethanol intake, ml/week 15.6 ± 21.5 16.2 ± 20.3 17.8 ± 22.5 17.3 ± 19.7 20.5 ± 22.8 0.010
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(P = 0.05; Supplemental Table 6). There were no significant 
associations between egg consumption and other markers of 
cardiovascular risk (Supplemental Table 5).
Discussion
In the CAPS no overall associations between weekly egg 
consumption up to 5 eggs/week and risk of total CVD, MI, 
heart failure, all-cause mortality and T2D were observed 
after a mean follow-up of 22.8 years, but there was a sig-
nificant positive trend in stroke risk across the quantiles of 
egg intake. Further sub-group analysis showed that the sig-
nificant trend disappeared after the men with T2D and/or 
IGT were removed. However the association of egg intake 
and risk of stroke in the sub-group of T2D and/or IGT only, 
showed significant positive associations. Secondary analy-
ses in both CAPS and NDNS showed increased fasting glu-
cose with higher egg intake in the sub-group of T2D and/
or IGT. In addition, results of cross-sectional analyses of 
NDNS showed higher egg intake was associated with higher 
HbA1c in the general healthy population across tertiles of 
egg intake.
These results are consistent with the previous meta-
analyses of prospective studies [13, 14], which showed no 
association between egg consumption and CVD events in 
the general population. Very few studies have reported a 
positive association between egg intake and CVD risk. Nev-
ertheless, data from Physicians’ Health Study [25] indicated 
the HR of heart failure was 1.33 (95% CI 1.04, 1.70) with 
Table 2  Longitudinal study of incidence of stroke, myocardial infarction, heart failure and all-cause mortality according to egg consumption of 
all subjects from the caerphilly prospective cohort study
a Values are hazard ratios (95% CIs) derived by Cox proportional hazards regression models adjusted for age (continuous), BMI (continuous), 
total energy intake (continuous), alcohol consumption (quartiles), smoking (never, past or current), energy expenditure (quartiles), social class 
(manual or non-manual), family history of myocardial infarction (yes or no), diabetes mellitus (yes or no)
b Adjusted as model 1 plus sugar intake (< 50, 50–100, > 100 g/day), fruit consumption (< 7, 8–14, 15–21, or > 21 times/week), red meat con-
sumption (< 7, 8–14, 15–21, or > 21 times/week) and fibre (cereal and vegetable sources) (< 10, 10–20, or > 20 g/day)
Characteristics Egg consumption (n, eggs/week) P-trend
(0 ≤ n ≤ 1) (1 < n ≤ 2) (2 < n ≤ 3) (3 < n < 5) (n ≥ 5)
Total subjects, n 274 464 469 318 256
Total CVD events
 No. of events 103 166 195 129 122
 HR (non-adjust) 1 0.95 (0.74, 1.21) 1.12 (0.88, 1.42) 1.08 (0.83, 1.40) 1.37 (1.05, 1.78) 0.007
 HR (adjusted Model 1)a 1 0.97 (0.75, 1.24) 1.11 (0.87, 1.42) 1.02 (0.78, 1.34) 1.26 (0.95, 1.67) 0.09
 HR (adjusted Model 2)b 1 0.98 (0.76, 1.26) 1.14 (0.89, 1.46) 1.01 (0.77, 1.33) 1.25 (0.94, 1.66) 0.12
Stroke
 No. of events 33 57 57 48 53
 HR (non-adjust) 1 1.01 (0.66, 1.56) 1.01 (0.66, 1.55) 1.27 (0.82, 1.98) 1.82 (1.18, 2.80) 0.002
 HR (adjusted Model 1)a 1 0.99 (0.65, 1.53) 0.97 (0.63, 1.50) 1.14 (0.72, 1.81) 1.58 (1.00, 2.52) 0.03
 HR (adjusted Model 2)b 1 1.01 (0.65, 1.56) 1.00 (0.64, 1.55) 1.15 (0.72, 1.84) 1.60 (1.00, 2.57) 0.04
Myocardial infarction
 No. of events 73 117 137 86 64
 HR (non-adjust) 1 0.94 (0.70, 1.26) 1.11 (0.83, 1.47) 1.00 (0.73, 1.37) 0.94 (0.67, 1.31) 0.98
 HR (adjusted Model 1) 1 0.96 (0.71, 1.29) 1.10 (0.83, 1.48) 0.99 (0.71, 1.37) 0.90 (0.63, 1.29) 0.75
 HR (adjusted Model 2) 1 0.97 (0.72, 1.31) 1.14 (0.85, 1.52) 1.01 (0.72, 1.40) 0.91 (0.64, 1.31) 0.80
Heart failure
 No. of events 29 33 63 44 32
 HR (non-adjust) 1 0.66 (0.40, 1.09) 1.29 (0.83, 2.00) 1.33 (0.83, 2.13) 1.20 (0.72, 1.98) 0.03
 HR (adjusted Model 1) 1 0.64 (0.39, 1.06) 1.17 (0.74, 1.83) 1.10 (0.67, 1.79) 0.89 (0.52, 1.52) 0.46
 HR (adjusted Model 2) 1 0.65 (0.39, 1.08) 1.19 (0.76, 1.88) 1.09 (0.66, 1.81) 0.89 (0.51, 1.53) 0.49
All-cause mortality
 No. of events 135 249 293 187 164
 HR (non-adjust) 1 1.13 (0.92, 1.40) 1.35 (1.10, 1.66) 1.25 (1.00, 1.56) 1.44 (1.14, 1.80) 0.001
 HR (adjusted Model 1) 1 1.08 (0.87, 1.33) 1.21 (0.98, 1.49) 1.03 (0.82, 1.30) 1.11 (0.87, 1.42) 0.58
 HR (adjusted Model 2) 1 1.08 (0.87, 1.34) 1.20 (0.98, 1.49) 1.02 (0.81, 1.29) 1.08 (0.84, 1.38) 0.80
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egg consumption ≥ 7 per week compared with that of < 1 
per week over 20 years of follow-up for physicians free of 
previous MI. In addition, in another analysis of the same 
cohort there was no association between egg intake and MI 
and stroke, but there was a significant positive association 
with all-cause mortality [26]. The difference in the observed 
association of egg consumption and heart failure or all-cause 
mortality between the current study and that by Djousse 
et al. [25, 26] may be due to differences in the characteris-
tics of the investigated subjects. Physicians were included 
in the study of Djousse et al. [25, 26], whereas 64% of the 
men in the current study were manual workers. An earlier 
British study in 1997 reported a 2.68 times increased risk 
of ischaemic heart disease deaths in 10,802 subjects report-
ing higher egg intake (> 6/week) compared with lower egg 
consumption (< 1 egg/week) after 13.3 years follow-up [27]. 
In our study we were not able to conduct a similar analysis, 
as the data for mortality resulting from different categories 
of heart disease were not available.
Our finding of no association between egg intake and risk 
of stroke in generally healthy men is consistent with previ-
ous studies [28–30]. However, in our sub-group analysis of 
340 men with T2D and/or IGT, we found a significant posi-
tive association between egg intake and the risk of stroke. 
Table 3  Longitudinal analysis of incident of stroke according to egg consumption in subjects with and without type 2 diabetes and/or impaired 
glucose tolerance from the Caerphilly Prospective Cohort study
a Impaired glucose tolerance, i.e., fasting glucose ≥ 6.1 mmol/L
b Values are hazard ratios (95% CIs) derived by Cox proportional hazards regression models adjusted for age (continuous), BMI (continuous), 
total energy intake (continuous), alcohol consumption (quartiles), smoking (never, past or current), energy expenditure (quartiles), social class 
(manual or non-manual), family history of myocardial infarction (yes or no)
c Adjusted as model 1 plus sugar intake (< 50, 50–100, > 100 g/day), fruit consumption (< 7, 8–14, 15–21, or > 21 times/week), red meat con-
sumption (< 7, 8–14, 15–21, or > 21 times/week) and fibre (cereal and vegetable sources) (< 10, 10–20, or > 20 g/day)
Egg consumption (n, eggs/week) P-trend
(0 ≤ n ≤ 1) (1 < n ≤ 2) (2 < n ≤ 3) (3 < n < 5) (n ≥ 5)
Subjects without T2D and/or  IGTa
 Total subjects, n 221 397 378 248 197
 No. of events 25 47 45 34 31
 HR (non-adjust) 1 1.05 (0.64, 1.70) 1.05 (0.65, 1.72) 1.23 (0.73, 2.05) 1.45 (0.85, 2.45) 0.12
 HR (adjusted Model 1)b 1 1.01 (0.62, 1.66) 0.97 (0.59, 1.60) 1.14 (0.67, 1.95) 1.28 (0.73, 2.24) 0.33
 HR (adjusted Model 2)c 1 1.05 (0.64, 1.71) 1.01 (0.61, 1.66) 1.17 (0.68, 2.02) 1.32 (0.75, 2.34) 0.29
Subjects with T2D and/or IGT
 Total Subjects, n 53 67 91 70 59
 No. of events 8 10 12 14 22
 HR (non-adjust) 1 0.96 (0.38, 2.44) 0.86 (0.35, 2.10) 1.35 (0.57, 3.23) 2.71 (1.21, 6.09) 0.003
 HR (adjusted Model 1) 1 1.10 (0.42, 2.86) 1.02 (0.40, 2.62) 1.35 (0.53, 3.43) 2.83 (1.15, 6.96) 0.01
 HR (adjusted Model 2) 1 1.09 (0.41, 2.88) 0.96 (0.37, 2.50) 1.39 (0.54, 3.56) 2.87 (1.13, 7.27) 0.01
Table 4  Longitudinal study of incidence of type 2 diabetes according to egg consumption from the caerphilly prospective cohort study
a Values are hazard ratios (95% CIs) derived by Cox proportional hazards regression models adjusted for age (continuous), BMI (continuous), 
total energy intake (continuous), alcohol consumption (quartiles), smoking (never, past or current), energy expenditure (quartiles), social class 
(manual or non-manual), family history of myocardial infarction (yes or no)
b Adjusted as model 1 plus sugar intake (< 50, 50–100, > 100 g/d), fruit consumption (< 7, 8–14, 15–21, or > 21 times/week), red meat consump-
tion (< 7, 8–14, 15–21, or > 21 times/week) and fibre (cereal and vegetable sources) (< 10, 10–20, or > 20 g/day)
Egg consumption (n, eggs/week) P-trend
(0 ≤ n ≤ 1) (1 < n ≤ 2) (2 < n ≤ 3) (3 < n < 5) (n ≥ 5)
Total subjects, n 259 447 453 290 238
No. of events 17 31 35 21 16
HR (non-adjust) 1 1.17 (0.65, 2.12) 1.24 (0.69, 2.21) 1.20 (0.63, 2.27) 1.22 (0.61, 2.41) 0.59
HR (adjusted Model 1)a 1 1.08 (0.59, 1.97) 1.05 (0.57, 1.92) 1.25 (0.64, 2.44) 1.23 (0.60, 2.53) 0.48
HR (adjusted Model 2)b 1 1.05 (0.57, 1.93) 1.02 (0.55, 1.88) 1.24 (0.63, 2.45) 1.31 (0.63, 2.73) 0.39
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A few epidemiological studies [13, 14] have investigated 
the association of egg consumption and CVD in T2D sub-
jects, but none have included participants with IGT. A recent 
review has summarised the conflicting evidence and con-
cluded that a diet including more eggs than is recommended 
(at least in some countries) may be used safely for all of the 
population which includes those with T2D [31]. Our study 
is not totally supportive of this statement and to the best of 
our knowledge; we are the first to show a positive association 
between egg consumption and stroke in subjects with T2D 
and/or IGT, which needs confirmation in further studies.
In our secondary cross-sectional analysis of CAPS and 
NDNS, a positive association between egg intake and blood 
glucose was observed in the T2D and/or IGT subgroup. This 
may indicate that higher egg intake had a detrimental effect 
on the glucose metabolism in subjects with T2D and/or IGT, 
although this needs confirmation in randomized controlled 
dietary intervention trials. An earlier study also showed that 
higher egg consumption was associated with elevated fast-
ing glucose in 394 middle-aged healthy men [7]. This is 
also supported by another cross-sectional analysis [32] that 
observed significant positive relationships between egg con-
sumption and fasting glucose, insulin or insulin resistance, 
although the difference was very small. However, neither of 
these studies investigated the association in sub-groups with 
T2D and/or IGT [7, 32].
The concept of eggs as a cholesterol rich food, which 
may increase LDL-cholesterol and risk of heart disease, has 
been recognised for a long time. However, in our analysis, 
we found no association between egg intake and blood cho-
lesterol concentrations, in agreement with Gray and Griffin 
[10] who concluded that the effect of dietary cholesterol on 
LDL-cholesterol was negligible compared with the effect 
of dietary saturated fatty acids. In contrast to our findings, 
a study in a Finnish population showed a reduction in fast-
ing plasma glucose in the highest egg consumption quar-
tile (> 45 g/day) at baseline and after a 4-year follow-up in 
2312 men [12]. This significant association at baseline only 
appeared when dietary cholesterol intake was included as a 
covariate. However, controlling for dietary cholesterol may 
lead to bias as this component of eggs could be responsible 
for the observed effects of eggs on plasma glucose [33].
Lastly, this is the first study to show a strong positive 
association between higher egg intake and elevated HbA1c 
concentration in a population without CVD or known 
T2D by using NDNS. Higher HbA1c is regarded as an 
important marker for pre-diagnosed T2D and CVD [34, 
35]. There was no evidence in CAPS of any association 
between egg consumption and the development of T2D. 
However in a larger study, Djousse and colleagues [36] 
showed a significant positive association between egg 
consumption (≥ 7 weekly) and risk of T2D in two large 
prospective cohort studies of men (n = 20,303) and women 
(n = 36,295) with 1921 and 2112 cases of T2D after a fol-
low-up period of 20.0 years for men and 11.7 years for 
women, respectively. One possible explanation for the 
non-significant finding in CAPS is the numbers of self-
reported T2D cases were relatively small and were not 
validated by clinical diagnosis. Nevertheless, our study 
agrees with the recent meta-analysis [37] which identified 
12 prospective cohort studies and showed infrequent egg 
consumption was not associated with risk of T2D.
The potential mechanism by which eggs could increase 
fasting plasma glucose and ischaemic stroke in those with 
T2D and/or IGT is unclear. Findings from a 3-month ran-
domized controlled study showed that there was no nega-
tive effect of higher egg consumption (> 12 eggs/week) on 
blood lipid profile compared with low egg consumption 
(< 2 eggs/week) in overweight or obese subjects diagnosed 
with diabetes or prediabetes [11]. However, in that study 
the authors controlled for diabetes or prediabetes drug use 
which may have masked the effect of egg consumption.
The major strength of the CAPS study is that it has a 
follow-up of over 20 years, which is one of the longest 
UK prospective cohort studies providing new evidence on 
the relationship between dietary factors and CVD events. 
Furthermore, to prevent chance findings, the cross-sec-
tional analyses were repeated in two phases (Phase 2 and 
3) of the CAPS (5-year interval). However, egg consump-
tion was only recorded as the weekly egg intake and did 
not account for eggs consumed from composite dishes 
or purchased foods. Thus, egg intakes may have been 
underestimated or misclassified, which may have affected 
the observed associations. In addition, cooking methods 
and information on how eggs were consumed were not 
recorded, which may have had effects on health outcomes 
[38]. In terms of the metabolic markers available in CAPS, 
insulin was only measured in a small proportion of sub-
jects and was not measured in Phase 3, thus insulin resist-
ance could not be estimated.
In conclusion, our study showed no evidence for adverse 
effects of infrequent egg intake (3 eggs per week) on the 
risk of CVD, T2D and all-cause mortality in healthy men. 
However, a detrimental association of infrequent egg intake 
(3 eggs per week) on fasting glucose and risk of ischae-
mic stroke in T2D and/or IGT subjects was observed and 
an adverse cross-sectional association of egg consumption 
on HbA1C in a generally healthy population. However, due 
to the limited sample size and number of events and deaths, 
cautious interpretation of these results is recommended. 
In addition, residual confounding factors may have influ-
enced the association between egg consumption and health 
outcomes [39]. As eggs are rarely consumed alone, further 
research should explore the dietary pattern of high and low 
egg consumers, and large prospective cohort studies and 
RCTs are required to verify these findings in the future.
2951Eur J Nutr (2018) 57:2943–2952 
1 3
Acknowledgements We thank Professor Yoav Ben-Shlomo, School 
of Social and Community Medicine, University of Bristol for managing 
the release of data from the CAPS.
Author contributions The authors’ responsibilities were as fol-
lows: JAL and DIG designed the research; JG and DAH conducted the 
research; JG and DAH analysed the data with guidance from JEP; JG, 
DAH, DIG and JAL wrote the paper; PCE and JRC contributed exper-
tise on epidemiology and CVD respectively. DIG and JAL had primary 
responsibility for the final content of the manuscript. All authors read 
and approved the final manuscript.
Compliance with ethical standards 
Conflict of interest The authors declare that they have no conflict 
of interest.
Open Access This article is distributed under the terms of the 
Creative Commons Attribution 4.0 International License (http://crea-
tivecommons.org/licenses/by/4.0/), which permits unrestricted use, 
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to 
the Creative Commons license, and indicate if changes were made.
References
 1. Buttar HS, Li T, Ravi N (2005) Prevention of cardiovascular dis-
eases: role of exercise, dietary interventions, obesity and smoking 
cessation. Exp Clin Cardiol 10: 229–249
 2. Ley SH, Hamdy O, Mohan V, Hu FB (2007) Prevention and 
management of type 2 diabetes: dietary components and 
nutritional strategies. Lancet 383:1999–2007. doi:10.1016/
S0140-6736(14)60613-9
 3. Benelam B, Roe M, Pinchen H, Church S, Buttriss J, 
Gray J, Finglas P (2012) New data on the nutritional 
composition of UK hens’ eggs. Nutr Bull 37:344–349. 
doi:10.1111/j.1467-3010.2012.01993.x
 4. Finglas PM, Roe MA, Pinchen HM, Berry R, Church SM, Dodhia 
SK, Farron-Wilson M, Swan G (2014) McCance and Widdow-
son’s the composition of foods (seventh summary edition ed.). 
Royal Society of Chemistry, Cambridge
 5. Adamopoulos PN, Papamichael CM, Zampelas A, Moulopoulos 
SD (1996) Cholesterol and unsaturated fat diets influence lipid and 
glucose concentrations in rats. Comp Biochem Physiol B Biochem 
Mol Biol 113: 659 – 63
 6. Lewis KE, Kirk EA, McDonald TO, Wang SR, Wight TN, 
O’Brien KD, Chait A (2004) Increase in serum amyloid A 
evoked by dietary cholesterol is associated with increased ath-
erosclerosis in mice. Circulation 110:540–545. doi:10.1161/01.
Cir.0000136819.93989.E1
 7. Feskens EJ, Kromhout D (1990) Habitual dietary intake and glu-
cose tolerance in euglycaemic men: the Zutphen Study. Int J Epi-
demiol 19:953–959
 8. Weggemans RM, Zock PL, Katan MB (2001) Dietary cholesterol 
from eggs increases the ratio of total cholesterol to high-density 
lipoprotein cholesterol in humans: a meta-analysis. Am J Clin 
Nutr 73:885–891
 9. Berger S, Raman G, Vishwanathan R, Jacques PF, Johnson EJ 
(2015) Dietary cholesterol and cardiovascular disease: a sys-
tematic review and meta-analysis. Am J Clin Nutr 102:276–294. 
doi:10.3945/ajcn.114.100305
 10. Gray J, Griffin B (2009) Eggs and dietary cholesterol–dispelling the 
myth. Nutr Bull 34:66–70. doi:10.1111/j.1467-3010.2008.01735.x
 11. Fuller NR, Caterson ID, Sainsbury A, Denyer G, Fong M, Gerofi 
J, Baqleh K, Williams KH, Lau NS, Markovic TP (2015) The 
effect of a high-egg diet on cardiovascular risk factors in people 
with type 2 diabetes: the Diabetes and Egg (DIABEGG) study-a 
3-mo randomized controlled trial. Am J Clin Nutr 101:705–713. 
doi:10.3945/ajcn.114.096925
 12. Virtanen JK, Mursu J, Tuomainen TP, Virtanen HE, Voutilainen 
S (2015) Egg consumption and risk of incident type 2 diabetes 
in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. 
Am J Clin Nutr 101:1088–1096. doi:10.3945/ajcn.114.104109
 13. Rong Y, Chen L, Zhu T, Song Y, Yu M, Shan Z, Sands A, Hu 
FB, Liu L (2013) Egg consumption and risk of coronary heart 
disease and stroke: dose-response meta-analysis of prospective 
cohort studies. BMJ 346:e8539. doi:10.1136/bmj.e8539
 14. Shin JY, Xun P, Nakamura Y, He K (2013) Egg consumption 
in relation to risk of cardiovascular disease and diabetes: a sys-
tematic review and meta-analysis. Am J Clin Nutr 98: 146–159. 
doi:10.3945/ajcn.112.051318
 15. Alexander DD, Miller PE, Vargas AJ, Weed DL, Cohen SS 
(2016) Meta-analysis of egg consumption and risk of coronary 
heart disease and stroke. J Am Coll Nutr 35:704–716. doi:10.1
080/07315724.2016.1152928
 16. Scott J (2004) Pathophysiology and biochemistry of cardiovas-
cular disease. Curr Opin Genet Dev 14:271–279. doi:10.1016/j.
gde.2004.04.012
 17. Caerphilly and Speedwell collaborative heart disease studies 
(1984) The Caerphilly and Speedwell collaborative group. J 
Epidemiol Community Health 38: 259–262
 18. Fehily AM, Yarnell J, Butland BK (1987) Diet and ischaemic 
heart disease in the Caerphilly Study. Hum Nutr Appl Nutr 41: 
319 – 26
 19. Bainton D, Baker IA, Sweetnam PM, Yarnell JW, Elwood PC 
(1988) Prevalence of ischaemic heart disease: the Caerphilly 
and Speedwell surveys. Br Heart J 59:201–206
 20. Greenwood R, McCarron P, Elwood P, Shlomo YB, Bayer A, 
Baker I, Frankel S, Ebrahim S, Murray L, Smith GD (2001) 
The incidence and aetiology of stroke in the Caerphilly and 
Speedwell Collaborative Studies I: methods and incidence of 
events. Public Health 115:4–11. doi:10.1038/sj.ph.1900723
 21. Elwood PC, Beswick A, Pickering J, McCarron P, O’Brien JR, 
Renaud SR, Flower RJ (2011) Platelet tests in the prediction of 
myocardial infarction and ischaemic stroke: evidence from the 
Caerphilly Prospective Study. Br J Haematol 2:514–520
 22. World Health Organization (2006) Definition and Diagnosis of 
diabetes mellitus and intermediate hyperglycemia: report of a 
WHO/IDF consultation. World Health Organization, Geneva
 23. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation 
of the concentration of low-density lipoprotein cholesterol in 
plasma, without use of the preparative ultracentrifuge. Clin 
Chem 18:499–502
 24. Bates B, Lennox A, Prentice A, Bates C, Page P, Nicholson S, 
Swan G (2014) National Diet and Nutrition Survey: headline 
results from years 1 and 4 combined of the rolling programme 
2008/2009–2011/12). Department of Health
 25. Djousse L, Gaziano JM (2008) Egg consumption and risk 
of heart failure in the Physicians’ Health Study. Circulation 
117:512–516. doi:10.1161/CIRCULATIONAHA.107.734210
 26. Djousse L, Gaziano JM (2008) Egg consumption in relation to 
cardiovascular disease and mortality: the Physicians’ Health 
Study. Am J Clin Nutr 87:964–969
 27. Mann JI, Appleby PN, Key TJ, Thorogood M (1997) Dietary 
determinants of ischaemic heart disease in health conscious 
individuals. Heart 78:450–455
2952 Eur J Nutr (2018) 57:2943–2952
1 3
 28. Bernstein AM, Pan A, Rexrode KM, Stampfer M, Hu FB, 
Mozaffarian D, Willett WC (2012) Dietary protein sources 
and the risk of stroke in men and women. Stroke 43:637–644. 
doi:10.1161/Strokeaha.111.633404
 29. Larsson SC, Akesson A, Wolk A (2015) Egg consumption and 
risk of heart failure, myocardial infarction, and stroke: results 
from 2 prospective cohorts. Am J Clin Nutr 102:1007–1013. 
doi:10.3945/ajcn.115.119263
 30. Qureshi AI, Suri FK, Ahmed S, Nasar A, Divani AA, Kirmani 
JF (2007) Regular egg consumption does not increase the risk of 
stroke and cardiovascular diseases. Med Sci Monit 13:CR1-8
 31. Fuller NR, Sainsbury A, Caterson ID, Markovic TP (2015) Egg 
consumption and human cardio-metabolic health in people with 
and without diabetes. Nutrients 7:7399–7420. doi:10.3390/
nu7095344
 32. Djousse L, Kamineni A, Nelson TL, Carnethon M, Mozaffarian 
D, Siscovick D, Mukamal KJ (2010) Egg consumption and risk 
of type 2 diabetes in older adults. Am J Clin Nutr 92:422–427. 
doi:10.3945/ajcn.2010.29406
 33. Kamangar F (2012) Confounding variables in epidemiologic stud-
ies: basics and beyond. Arch Iran Med 15:508–516. doi:012158/
AIM.0014
 34. Peters AL, Davidson MB, Schriger DL, Hasselblad V (1996) A 
clinical approach for the diagnosis of diabetes mellitus: an analy-
sis using glycosylated hemoglobin levels. Meta-analysis Research 
Group on the Diagnosis of Diabetes Using Glycated Hemoglobin 
Levels. JAMA 276:1246–1252
 35. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, 
Pankow J, Coresh J, Brancati FL (2010) Glycated hemoglobin, 
diabetes, and cardiovascular risk in nondiabetic adults. N Engl J 
Med 362:800–811. doi:10.1056/NEJMoa0908359
 36. Djousse L, Gaziano JM, Buring JE, Lee IM (2009) Egg consump-
tion and risk of type 2 diabetes in men and women. Diabetes Care 
32:295–300. doi:10.2337/dc08-1271
 37. Djousse L, Khawaja OA, Gaziano JM (2016) Egg consumption 
and risk of type 2 diabetes: a meta-analysis of prospective studies. 
Am J Clin Nutr 103:474–480. doi:10.3945/ajcn.115.119933
 38. Nimalaratne C, Schieber A, Wu J (2016) Effects of storage and 
cooking on the antioxidant capacity of laying hen eggs. Food 
Chem 194:111–116. doi:10.1016/j.foodchem.2015.07.116
 39. Nicklas TA, O’Neil CE, Fulgoni VL (2015) Differing statistical 
approaches affect the relation between egg consumption, adipos-
ity, and cardiovascular risk factors in adults. J Nutr 145:170–176. 
doi:10.3945/jn.114.194068
